Bioxyne (ASX:BXN) Other Gross PPE : A$0.00 Mil (As of Dec. 2023)

View and export this data going back to 2000. Start your Free Trial

What is Bioxyne Other Gross PPE?

Bioxyne's Other Gross PPE for the quarter that ended in Dec. 2023 was A$0.00 Mil.

Bioxyne's quarterly Other Gross PPE increased from Dec. 2022 (A$0.00 Mil) to Jun. 2023 (A$0.02 Mil) but then declined from Jun. 2023 (A$0.02 Mil) to Dec. 2023 (A$0.00 Mil).

Bioxyne's annual Other Gross PPE declined from Jun. 2021 (A$0.29 Mil) to Jun. 2022 (A$0.08 Mil) and declined from Jun. 2022 (A$0.08 Mil) to Jun. 2023 (A$0.02 Mil).

Bioxyne Other Gross PPE Historical Data

The historical data trend for Bioxyne's Other Gross PPE can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bioxyne Other Gross PPE Chart

Bioxyne Annual Data

Trend

Jun14

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Other Gross PPE

Get a 7-Day Free Trial

0.16

0.29

0.08

0.02

Bioxyne Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Other Gross PPE	Get a 7-Day Free Trial															-	0.08	-	0.02	-

Bioxyne Other Gross PPE Calculation

GuruFocus lists Land And Improvements, Buildings And Improvements, Machinery, Furniture, Equipment, Construction In Progress and Other Gross PPE under the "Gross Property, Plant and Equipment" section.

Bioxyne (ASX:BXN) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Bioxyne Ltd (ASX:BXN) » Definitions » Other Gross PPE

Comparable Companies

Traded in Other Exchanges

N/A

Address

50 Clarence Street, Suite 506, Level 5, Sydney, NSW, AUS, 2000

Website

https://www.bioxyne.com

Bioxyne Ltd is an Australian life science and health products company. The company is engaged in the development, manufacture, and distribution of consumer dietary supplements based on the proprietary probiotic strain of Lactobacillus Fermentum PCC. Some of its products include Breathe life Science, Dr Watson, BLS Clinics, Mirai Solution, CanXChange etc. It operates in three segments: wholesale sales, Plant based and direct sales. The majority of the revenue is generated from Plant based in the United Kingdom, Europe and Japan.

Bioxyne (ASX:BXN) Headlines

No Headlines